Special Instructions 018 Issuance for Easy Broad Agency Announcement (EZ-BAA)
Closed Special Notice Posted
Not the latest version. See the latest special notice from .
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Washington, District of Columbia 20201, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice from the Department of Health and Human Services announces revisions to the Easy Broad Agency Announcement solicitation number BAA-20-100-SOL-0002 issued by the Biomedical Advanced Research and Development Authority. BARDA revises descriptions of Areas of Interest focusing on at-home laboratory testing, digital health tools for pandemic preparedness, home-based SARS-CoV-2 diagnostics, and enabling decentralized testing. BARDA also adds an Area of Interest on enrolling patients in clinical trials of host-directed therapeutics based on biomarkers.
The Special Notice seeks to solicit innovations from eligible contractors in areas such as at-home laboratory testing platforms, digital health tools for pandemic preparedness, home-based SARS-CoV-2 diagnostics, technologies enabling decentralized testing, and strategies for enrolling patients in clinical trials of host-directed therapeutics based on biomarkers or clinical characteristics. Contractors can develop solutions responsive to the revised AOI descriptions and submit abstracts before specified closing dates in 2022 and 2023 for potential multiple awards under $750,000 total government funding per award. Responsive submissions will be accepted for certain AOIs by March 31, 2022, April 29, 2022, and July 29, 2022.
Notice text
Under these Special Instructions 018, BARDA is announcing the following as part of its EZ-BAA (BAA-20-100-SOL-0002):
1. Revising the descriptions of the following Areas of Interest (AOIs):
- AOI #8: Bringing Laboratory Testing to the Home
- AOI #9: Digital Health Tools for Pandemic Preparedness
- AOI #11a: Home-based, Over-the-Counter Diagnostics for the Detection of SARS-CoV-2
- AOI #11b: Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection
2. Adding AOI #13: Endotyping for Host-Directed Therapeutics to the EZ-BAA.
3. Update the closing dates for abstract submissions for multiple AOIs under the EZ-BAA.
Files
| File | Type | Posted |
|---|---|---|
| DRIVe EZ-BAA - Special Instructions 018.pdf |
Notice history
Show 5 more
15 notices listed here. See the rest on GovTribe.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity